{"schema_version":"secwatch.filing_event.v1","accession":"0001819790-26-000062","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2026-08-06T11:11:10+00:00","discovered_at":"2026-08-06T11:15:03.438163+00:00","generated_at":"2026-08-06T11:15:32.902455+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Tarsus Pharmaceuticals raises $125M in oversubscribed PIPE financing at $56/share","bullets":["Gross proceeds of ~$125M from sale of 2,098,519 shares at $56.00 and pre-funded warrants for 133,625 shares at $55.9999.","PIPE includes participation from Alkeus investors (TCGX, Bain Capital, Wellington) and new investors (ADAR1, Sirenia, RTW, Vestal Point).","Proceeds to fund clinical development, commercial activities, and general corporate purposes; closing expected Aug 7, 2026.","PIPE is in connection with pending acquisition of Alkeus Pharmaceuticals (announced separately).","Barclays lead placement agent; BofA Securities and William Blair co-placement agents."],"urls":{"canonical":"https://secwatch.observer/filing/0001819790-26-000062","json":"https://secwatch.observer/filing/0001819790-26-000062.json","markdown":"https://secwatch.observer/filing/0001819790-26-000062.md","text":"https://secwatch.observer/filing/0001819790-26-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000181979026000062/0001819790-26-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000181979026000062/tars-20260805.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T11:15:32.902455+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}